Christina L. Parker

Evading Immune Cell Uptake and Clearance Requires PEG Grafting at Densities Substantially Exceeding the Minimum for Brush Conformation

Qi Yang, Stephen Jones, Christina L. Parker et al. · Molecular Pharmaceutics · 2014 · 268 citations

Nanoparticles, Nanotherapeutics, Engineering +25

Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism

Sara Powell, Nadia Khan, Christina L. Parker et al. · Gene Therapy · 2016 · 86 citations · Full text

Molecular Virology, Preferential Oligodendrocyte Tropism, Pathogenesis +5

Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma

Simone Hettmer, Anna C. Schinzel, Daria Tchessalova et al. · eLife · 2015 · 59 citations · Full text

Tumor Biology, Functional Genomics, Oncogenic Agent +13

Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2

Christina L. Parker, Morgan D. McSweeney, Andrew T. Lucas et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 23 citations

Cell-based Drug Delivery, Nanomedicine, Engineering +10

Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium

Justin T. Huckaby, Christina L. Parker, Timothy M. Jacobs et al. · Angewandte Chemie International Edition · 2019 · 20 citations · Full text

Nanoparticles, Nanomedicine, Cell-based Drug Delivery +15